SJL2-1
SJL2-1 is a PRMT5 inhibitor with an IC50 value of 1.56 μM. It suppresses the proliferation, migration, and invasion of prostate cancer cells and induces apoptosis while causing cell cycle arrest at the G0/G1 phase. SJL2-1 targets intracellular PRMT5, inhibiting androgen receptor methylation and expression. It is applicable in research on early androgen-sensitive prostate cancer and advanced castration-resistant prostate cancer (CRPC) .
Product Specifications
Field of Research
Epigenetics & Chromatin, Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP34984_P050 100 µL
GABRA5 antibody - middle region (ARP34984_P050)
Sign In for Pricing
View Details 
MBS6396315-01 0.1 mL
TFAP4 (BHLHC41, Transcription Factor AP-4, Activating Enhancer-binding Protein 4, Class C Basic Helix-loop-helix Protein 41) (Biotin)
Sign In for Pricing
View Details MBS6396315-02 5x 0.1 mL
TFAP4 (BHLHC41, Transcription Factor AP-4, Activating Enhancer-binding Protein 4, Class C Basic Helix-loop-helix Protein 41) (Biotin)
Sign In for Pricing
View Details